ChemoCentryx, Inc. (NASDAQ:CCXI)

CAPS Rating: 4 out of 5

Results 1 - 5 of 5

Recs

0
Member Avatar Aurum (73.58) Submitted: 7/29/2014 12:48:33 PM : Outperform Start Price: $5.72 CCXI Score: +42.83

Part of a broader pick of micro cap biotechs with encouraging preliminary clinical trial data and significant upside.

Recs

0
Member Avatar Chemdawg (25.90) Submitted: 10/7/2013 7:03:35 PM : Outperform Start Price: $5.30 CCXI Score: +35.19

huge stock price falloff because of a Crohns diease drug? You gotta be s#itting me.....biotechs have a bright future with ACA on the horizon and this will be one of the better bets to rebound..

Recs

0
Member Avatar TerryHoodSr (76.87) Submitted: 9/6/2013 2:16:12 PM : Outperform Start Price: $6.39 CCXI Score: +8.60

spec

Recs

0
Member Avatar 007mercucio (20.83) Submitted: 9/1/2013 10:13:19 AM : Outperform Start Price: $8.21 CCXI Score: -23.57

This stock is so oversold right now. They have 10 drugs in the pipeline. Their drug development engine algorithmically automates the development of new drug molecules. There is still a -chance- for Vercirnon, despite the recent SHIELD-1 Phase 3 study results (they are still investigating the methodology of the study). AND the stock is trending back from its recent fall. This is THE BEST time to get in on CCXI.

Recs

0
Member Avatar fatmoneyrz (99.25) Submitted: 8/24/2013 10:00:14 AM : Outperform Start Price: $11.40 CCXI Score: -52.98

My timing was terrible on this buy, still CCXI has a strong balance sheet, and many nice early stage candidates in their pipeline. I expect this goes back to its high with time.

Results 1 - 5 of 5

Featured Broker Partners


Advertisement